TRIGEMINAL NERVE RESPONSIBLE FOR CHRONIC TENSION TYPE HEADACHES. TRIGGER POINTS IN CRANIO-CERVICAL MUSCLES ARE MEDIATED BE TRIG

ANOTHER ARTICLE REINFORCES THAT CHRONIC TENSION TYPE HEADACHES ARE MEDIATED BY THE TRIGEMNAL NERVE. HEADACHES MEDIATED BY THE TRIGEMINAL NERVE WILL ALMOST ALWAYS RESPON POSITIVELY TO NEUROMUSCULAR DENTISTRY COMBINED WITH TRIGGER POINT THERAPY AND SPHENOPALATINE GANGLION BLOCKS.

A DIAGNOSTIC NEUROMUSCULAR ORTHOTIC CAN FREQUENTLY ELIMINATE OR GREATLY REDUCE HEADACHE PAIN. THE WEBSITE HTTP://WWW.IHATEHEADACHES.ORG HAS EXTENSIVE INFORMATION ON TRIGEMINOVASCULAR CAUSES OF HEADACHE.

Discov Med. 2009 Dec;8(43):232-6.
What do we know about chronic tension-type headache?
Fernández-de-Las-Peñas C.

Department of Physical Therapy, Universidad Rey Juan Carlos, Alcorcon, Madrid 28922, Spain. cesar.fernandez@urjc.es
In the past few years there has been an increasing body of knowledge about etiological mechanisms of chronic tension type headache (CTTH), permitting a better understanding of this syndrome. It seems that CTTH diagnostic criteria should be modified to improve its differential diagnosis against migraine, since CTTH is a syndrome of “featureless” headaches characterized by nothing but pain in the head. It has been demonstrated that pressure pain hypersensitivity and pericranial muscle tenderness are both consequence and not causative factors of CTTH. An updated pain model has suggested that CTTH can be explained by referred pain from trigger points (TrPs) in the cranio-cervical muscles, mediated through the spinal cord and the trigeminal nerve nucleus caudalis. Different therapeutic strategies (pharmacological and non-pharmacological) are generally used for the management of these patients. CTTH is generally treated with non-steroidal anti-inflammatory drugs (NSAIDs), tricyclic antidepressants, and physical therapy, although the therapeutic efficacy of these approaches is controversial.